Radiopharm Theranostics Limited American Depositary Shares (RADX) — Financial Flexibility Index

Latest as of June 2026: 0.00x

Radiopharm Theranostics Limited American Depositary Shares (RADX) has a Financial Flexibility Index of 0.00x as of June 2026. Free cash flow of $0.00 (operating CF $-32.08 Million minus capex $32.08 Million) represents 0% of total liabilities ($37.81 Million). Check Radiopharm Theranostics Limited American (RADX) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Financial Flexibility Index

0.00x
Free Cash Flow / Total Liabilities

Free Cash Flow

$0.00
Operating CF − Capex

Total Liabilities

$37.81 Million
USD

Capital Expenditures

$32.08 Million
USD

Radiopharm Theranostics Limited American Depositary Shares Financial Flexibility Index (2022–2026)

Historical Financial Flexibility Index trend for Radiopharm Theranostics Limited American Depositary Shares across 5 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Radiopharm Theranostics Limited American.

Annual Financial Flexibility Index for Radiopharm Theranostics Limited American Depositary Shares (2022–2026)

Year-by-year free cash flow to debt coverage for Radiopharm Theranostics Limited American Depositary Shares. Explore Radiopharm Theranostics Limited American cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2026 0.00x $0.00 $-51.63 Million $37.81 Million ▲ +100.0%
2025 -0.84x $-36.65 Million $-36.65 Million $43.61 Million ▼ -63.4%
2024 -0.51x $-22.98 Million $-22.98 Million $44.68 Million ▲ +30.3%
2023 -0.74x $-21.67 Million $-23.20 Million $29.37 Million ▼ -181.8%
2022 0.90x $18.42 Million $-9.92 Million $20.42 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities